This may be of concern, especially for those at risk of developing certain arrhythmias
Deciding between Semaglutide GLP-1 and Zepbound for weight management requires a nuanced approach that accounts for various factors specific to each patients health profile and treatment goals
In phase 3 clinical trials, tirzepatide improved liver fibrosis in individuals with metabolic dysfunction-associated steatohepatitis (MASH) 4 , and outperformed semaglutide in the management of obesity 1 and type 2 diabetes 2
The potency and safety of Semaglutide have not been studied, and thus it has not been established for patients between 65 years and 75 years
To avoid muscle loss, combine semaglutide with two strength training sessions a week (minimum)
Together, T2D and obesity are regarded as potential risk factors implicated in the development and progression of Alzheimers disease (AD), which is the most common neurodegenerative disease and represents the most typical cause of dementia